NEW YORK, Feb 19 — Johnson & Johnson said today it had submitted for emergency use listing of its Covid-19 vaccine to the World Health Organisation (WHO).

The company said the process is a prerequisite to supply vaccines to the Covax vaccine program co-led by WHO, which aims to deliver doses to poor and middle-income countries.

J&J entered into an agreement in December in support of the Covax program.

The company and Gavi, which also co-leads the Covax program, expect to enter into an advance purchase agreement that would provide up to 500 million doses of the single-dose vaccine to Covax through 2022, J&J said. — Reuters

Advertisement